PureTech Health (UK) Performance
| PRTC Stock | 169.40 3.80 2.29% |
PureTech Health has a performance score of 3 on a scale of 0 to 100. The company holds a Beta of 0.42, which implies possible diversification benefits within a given portfolio. As returns on the market increase, PureTech Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding PureTech Health is expected to be smaller as well. PureTech Health plc right now holds a risk of 2.2%. Please check PureTech Health plc maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk , to decide if PureTech Health plc will be following its historical price patterns.
Risk-Adjusted Performance
3 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in PureTech Health plc are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, PureTech Health is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
1 | PureTech Health Share Price Crosses Below 50 Day Moving Average of 162.62 - MarketBeat | 09/25/2024 |
2 | PureTech Health Hits New 12-Month Low at 138.75 - MarketBeat | 10/02/2024 |
3 | On The My Stocks Page - Stock Traders Daily | 11/18/2024 |
| Begin Period Cash Flow | 149.9 M |
PureTech |
PureTech Health Relative Risk vs. Return Landscape
If you would invest 16,300 in PureTech Health plc on August 30, 2024 and sell it today you would earn a total of 640.00 from holding PureTech Health plc or generate 3.93% return on investment over 90 days. PureTech Health plc is generating 0.0838% of daily returns and assumes 2.1973% volatility on return distribution over the 90 days horizon. Simply put, 19% of stocks are less volatile than PureTech, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
PureTech Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for PureTech Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as PureTech Health plc, and traders can use it to determine the average amount a PureTech Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0381
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | PRTC | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.2 actual daily | 19 81% of assets are more volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.04 actual daily | 3 97% of assets perform better |
Based on monthly moving average PureTech Health is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of PureTech Health by adding it to a well-diversified portfolio.
PureTech Health Fundamentals Growth
PureTech Stock prices reflect investors' perceptions of the future prospects and financial health of PureTech Health, and PureTech Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PureTech Stock performance.
| Return On Equity | -0.22 | ||||
| Return On Asset | -0.13 | ||||
| Operating Margin | (230.55) % | ||||
| Current Valuation | 15.03 M | ||||
| Shares Outstanding | 239.42 M | ||||
| Price To Book | 1.57 X | ||||
| Price To Sales | 891.74 X | ||||
| Revenue | 750 K | ||||
| Gross Profit | 17.39 M | ||||
| EBITDA | (17.68 M) | ||||
| Net Income | (66.63 M) | ||||
| Total Debt | 25.34 M | ||||
| Book Value Per Share | 1.32 X | ||||
| Cash Flow From Operations | (105.92 M) | ||||
| Earnings Per Share | (0.24) X | ||||
| Total Asset | 693.97 M | ||||
| Retained Earnings | 83.82 M | ||||
About PureTech Health Performance
Assessing PureTech Health's fundamental ratios provides investors with valuable insights into PureTech Health's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the PureTech Health is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
PureTech Health is entity of United Kingdom. It is traded as Stock on LSE exchange.Things to note about PureTech Health plc performance evaluation
Checking the ongoing alerts about PureTech Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for PureTech Health plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| The company reported the revenue of 750 K. Net Loss for the year was (66.63 M) with profit before overhead, payroll, taxes, and interest of 17.39 M. | |
| PureTech Health generates negative cash flow from operations | |
| Over 79.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: On The My Stocks Page - Stock Traders Daily |
- Analyzing PureTech Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether PureTech Health's stock is overvalued or undervalued compared to its peers.
- Examining PureTech Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating PureTech Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of PureTech Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of PureTech Health's stock. These opinions can provide insight into PureTech Health's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for PureTech Stock Analysis
When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.